Northern Trust
INMB icon

Northern Trust’s INmune Bio INMB Stock Holding History

Northern Trust’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.4K Sell
37,670
-146,555
-80% -$203K ﹤0.01% 4230
2026
Q1 		$208K Buy
184,225
+8,576
+5% +$12.2K ﹤0.01% 3936
2025
Q4 		$274K Sell
175,649
-13,467
-7% -$24K ﹤0.01% 3866
2025
Q3 		$391K Buy
189,116
+24,699
+15% +$56.5K ﹤0.01% 3736
2025
Q2 		$380K Buy
164,417
+11,972
+8% +$87.9K ﹤0.01% 3739
2025
Q1 		$1.19M Buy
152,445
+46,484
+44% +$369K ﹤0.01% 3203
2024
Q4 		$495K Buy
105,961
+9,154
+9% +$47.7K ﹤0.01% 3661
2024
Q3 		$522K Buy
96,807
+68,748
+245% +$489K ﹤0.01% 3572
2024
Q2 		$247K Buy
28,059
+7,642
+37% +$75.3K ﹤0.01% 3783
2024
Q1 		$240K Sell
20,417
-4,652
-19% -$56.2K ﹤0.01% 3834
2023
Q4 		$282K Buy
25,069
+4,799
+24% +$40.2K ﹤0.01% 3752
2023
Q3 		$137K Hold
20,270
– – ﹤0.01% 3933
2023
Q2 		$184K Sell
20,270
-27
-0.1% -$217 ﹤0.01% 3859
2023
Q1 		$131K Buy
20,297
+1,191
+6% +$9.59K ﹤0.01% 4007
2022
Q4 		$121K Hold
19,106
– – ﹤0.01% 4029
2022
Q3 		$118K Hold
19,106
– – ﹤0.01% 4061
2022
Q2 		$169K Sell
19,106
-799
-4% -$5.95K ﹤0.01% 3987
2022
Q1 		$168K Hold
19,905
– – ﹤0.01% 4190
2021
Q4 		$203K Sell
19,905
-2,316
-10% -$34.3K ﹤0.01% 4190
2021
Q3 		$432K Buy
22,221
+8,272
+59% +$160K ﹤0.01% 3818
2021
Q2 		$245K Hold
13,949
– – ﹤0.01% 4065
2021
Q1 		$166K Buy
13,949
+1,575
+13% +$28.4K ﹤0.01% 4159
2020
Q4 		$213K Buy
+12,374
New +$117K ﹤0.01% 3946

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust's INMB Position: Q2 2026 in Review

Northern Trust reduced its INmune Bio (INMB) stake by 80% in Q2 2026, selling an estimated $203K and leaving 37,670 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Northern Trust first reported a position in INMB in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.19M in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Northern Trust held 37,670 shares of INmune Bio worth $61.4K as of Q2 2026.
  • Northern Trust sold 146,555 INmune Bio shares in Q2 2026, an estimated $203K.
  • INmune Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4230 holding.
  • Northern Trust first reported a position in INmune Bio in Q4 2020 and has held it in 23 quarters since.
  • Northern Trust's INmune Bio position peaked at $1.19M in Q1 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.